| 0 (0%) | 11-27 03:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 24.42  |
1-year : | 24.58 |
| Resists | First : | 20.91 |
Second : | 21.04 |
| Pivot price | 20.92 |
|||
| Supports | First : | 20.7 |
Second : | 17.22 |
| MAs | MA(5) : | 20.9 |
MA(20) : | 20.91  |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 40.1 |
D(3) : | 52.2 |
| RSI | RSI(14): 45.8 |
|||
| 52-week | High : | 21.04 | Low : | 20.52 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DDFS ] has closed above bottom band by 4.4%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 20.9 - 21.03 | 21.03 - 21.12 |
| Low: | 20.5 - 20.67 | 20.67 - 20.79 |
| Close: | 20.6 - 20.84 | 20.84 - 21.02 |
Mon, 14 Jul 2025
No Injuries Reported From Arrowsmith School Structure Fire - PtboCanada
Tue, 03 Jun 2025
Kisqali Benefit Lasts Across Age in Breast Cancer Subset - Cure Today
Wed, 11 Dec 2024
Adjuvant Olaparib Maintains iDFS Benefit in BRCA1/2+, HER2– Breast Cancer - OncLive
Tue, 10 Dec 2024
In-Depth Analysis: Ribociclib Plus NSAI Offers Sustained Survival Benefits in Early Breast Cancer - Cancer Therapy Advisor
Thu, 21 Nov 2024
DFDS: Turkish logistics acquisition reaches completion - Offshore-Energy.biz
Mon, 16 Sep 2024
Ribociclib Combo Yields Extended iDFS Benefit in HR+/HER2– Breast Cancer - CancerNetwork
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|